Search research articles

お問い合わせ

JoVEについて

概要リーダーシップブログ JoVEヘルプセンター

著者向け

出版プロセス編集委員会範囲と方針査読よくある質問投稿

図書館員向け

推薦の声購読アクセスリソース図書館諮問委員会よくある質問

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments アーカイブ

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教員リソースセンター教員サイト

プライバシーポリシー

関連する概念動画

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

What is Genetic Engineering?

What is Genetic Engineering?

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え

Same author

Harmonizing standards and resources for the medical genome.

Nature·2026

Same author

Enhancing STEMM Education Through Advanced Technologies and Collaborative Programs.

Journal of biomolecular techniques : JBT·2025

Same author

Novel humanized loss-of-function NF1 mouse model of juvenile myelomonocytic leukemia.

Blood advances·2025

Same author

Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental Group.

Transplantation and cellular therapy·2025

Same author

Conquering the gene and cell therapy viability crisis: A path paved by ASGCT.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Same author

Clearing the hurdles for CAR-T cell treatment.

Nature reviews. Immunology·2025

Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026

Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026

Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026

Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026

Same journal

Retraction.

Science (New York, N.Y.)·2026

Same journal

Making time.

Science (New York, N.Y.)·2026

関連記事をすべて見る

Search research articles

関連する実験動画

Updated: Jun 18, 2025

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

細胞と遺伝子療法の利用可能性

Rayne H Rouce¹, Matthew H Porteus²

¹Rayne H. Rouce is an associate professor at the Center for Cell and Gene Therapy, Dan L. Duncan Comprehensive Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.

Science (New York, N.Y.)

|August 1, 2024

まとめ

この要約は機械生成です。

革新的な細胞・遺伝子療法 (CGT) は重症疾患の治療に生命の変革をもたらしますしかし高額な費用がかかるためこれらの高度な医療介入を必要とする多くの患者にとって医療へのアクセスに大きな障壁があります

さらに関連する動画

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Published on: February 9, 2024

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

関連する実験動画

Last Updated: Jun 18, 2025

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Author Spotlight: Efficient Adeno-Associated Virus Isolation for Pre-Clinical Applications

Published on: February 9, 2024

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

科学分野:

バイオテクノロジー
遺伝学
腫瘍学
血液学
神経学

背景:

細胞と遺伝子療法 (CGTs) は壊滅的な病気の治療において重要な進歩を表しています
これらの革新的な治療法は癌,状細胞疾患,神経疾患などの治療に有望であることが示されています

研究の目的:

以前は治療できなかった病気を治療するためのCGTの変革の可能性を強調する
これらの先進的な治療法の高いコストと限られたアクセスの重要な障壁を特定し,対処する.

主な方法:

この分析は,CGTの発展と臨床効果に関する現在の理解をまとめています.
経済的な要因,特にCGTの高価格帯 (一用量300,000ドルから400万ドル) を検討しています.
この研究は,アクセシビリティの課題を克服するために,複数の利害関係者の協力の必要性を検討しています.

主要な成果:

CGTは壊滅的な病気の患者にとって驚くべき効果と希望を示しています
CGTの高額なコストは,患者の広範なアクセスを妨げています.
現在の価格設定モデルでは多くの適格な患者が治療の可能性のある治療を受けられない可能性があります

結論:

生命を変える細胞と遺伝子治療への平等なアクセスを達成するには学界,産業,投資家,資金提供者,規制当局,患者支援団体の協調的な努力が必要です
協力的な戦略は,CGTの突破口を,その恩恵を受けるすべての患者に利用できるようにするために不可欠です.
経済的な課題に取り組むことは,公衆衛生におけるCGTの潜在能力を最大限に発揮するために極めて重要です.